GetTopicDetailResponse(id=62e1125619db, topicName=趨化因子配體, introduction=, content=CXCR3 趨化因子配體, image=null, comments=0, allHits=212, url=null, type=1, isShow=1, status=1, isAdmin=null, adminId=5395722, adminEncryptionId=cade5395722, adminName=梅斯管理員, createdBy=cade5395722, createdName=梅斯管理員, createdAvatar=, createdTime=Sun Mar 30 21:26:02 CST 2025, time=2025-03-30, bannerImg=https://img.medsci.cn/202167/1623032167418_5160405.png, bannerImgH5=https://img.medsci.cn/202167/1623032167418_5160405.png, likes=0, followStatus=false, moduleDTOList=null, tagId=503062, tagList=[TagDto(tagId=503062, tagName=趨化因子配體)], ipAttribution=, topicAdmin=0, lengthMark=0)
[GetTopicListResponse(id=2258415, encodeId=34fd2258415e7, content=<a href='/topic/show?id=a997118e575d' target=_blank style='color:#2F92EE;'>#CXCR3#</a> <a href='/topic/show?id=62e1125619db' target=_blank style='color:#2F92EE;'>#趨化因子配體#</a>, objectTitle= 腫瘤免疫治療的新靶點(diǎn)：CXCR3及其配體, objectType=article, longId=869671, objectId=63898696e1c7, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20220804/1659603269411_8252897.webp, objectUrl=/article/show_article.do?id=63898696e1c7, replyNumber=0, likeNumber=34, createdTime=2025-03-30, rootId=0, userName=梅斯管理員, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=63898696e1c7, moduleTitle= 腫瘤免疫治療的新靶點(diǎn)：CXCR3及其配體, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=63898696e1c7)], followStatus=false, userIsMember=false, type=null, lengthMark=0)]
梅斯管理員
2025-03-30
